Author

William Avery

Observed name: W. Avery

Observed institutions: Howard Hughes Medical Institute, Harvard University, The University of Texas at San Antonio Health Science Center, Lyndra Therapeutics (United States), Momenta Pharmaceuticals (United States), Dana-Farber Cancer Institute, Xilio Therapeutics (United States)

OpenAlex ID: A5080011913

Synergistic drug combinations tend to improve therapeutically relevant selectivity

2009 · Joseph Lehár, Andrew S Krueger, et al. · Nature Biotechnology · 939

Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

2002 · Gaël G. McGill, Martin Horstmann, et al. · Cell · 761

PDF

Definitive Hematopoiesis Requires the Mixed-Lineage Leukemia Gene

2004 · Patricia Ernst, Jill K Fisher, et al. · Developmental Cell · 265

PDF

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

2015 · Nathaniel Washburn, Inessa Schwab, et al. · Proceedings of the National Academy of Sciences · 225

The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action

2007 · Margaret S. Lee, Lisa Johansen, et al. · Cancer Research · 115

Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug

2009 · Grant R Zimmermann, William Avery, et al. · Arthritis Research & Therapy · 54

PDF

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results

2017 · Eileen M. O’Reilly, James Roach, et al. · The Oncologist · 46

PDF

Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening

2012 · Richard J. Rickles, Winnie F. Tam, et al. · Molecular Cancer Therapeutics · 21

Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates.

2021 · Jennifer O'Neil, Wilson Guzman, et al. · Journal of Clinical Oncology · 16

M281: A Therapeutic Anti-FcRn Blocking Antibody for Rapid Clearance of IgG and IgG Autoantibodies in Immune Cytopenias and Other Auto/Allo-Immune Disease

2015 · Leona E Ling, Sucharita Roy, et al. · Blood · 11

Necuparanib combined with nab-paclitaxel + gemcitabine in patients with metastatic pancreatic cancer: Phase 2 results.

2017 · Eileen Mary O'Reilly, Devalingam Mahalingam, et al. · Journal of Clinical Oncology · 6

Adenosine A2A and Beta-2 Adrenergic Receptor Agonism: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening

2008 · Richard J. Rickles, Laura Pierce, et al. · Blood · 4

M402, a heparan sulfate mimetic and novel candidate for the treatment of pancreatic cancer.

2012 · Birgit Corinna Schultes, Martijn P.J.K. Lolkema, et al. · Journal of Clinical Oncology · 3

Pharmacokinetics of M118, unfractionated heparin and enoxaparin sodium in normal and 5/6 nephrectomized uremic rats

2009 · Dragomir Draganov, Teresa Wright, et al. · Toxicology Letters · 3

Preclinical Evaluation of CRx-501, a Potent Selective A2A Agonist as a Novel Drug Candidate for the Treatment of Multiple Myeloma

2008 · Richard J Rickles, Laura Pierce, et al. · Blood · 3

Ultra long‐acting oral therapies for Alzheimer's: Proof of principle

2020 · Richard E. Scranton, William Avery, et al. · Alzheimer s & Dementia · 2

PDF

Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies (P4-14.008)

2024 · Nilufer Seth, Rui Xu, et al. · Neurology · 1

THU0057 Targeting the Neonatal FC Receptor (FCRN) to Mediate Autoantibody Clearance in IgG-Driven Autoimmune Disease

2015 · L.E. Ling, S. Roy, et al. · Annals of the Rheumatic Diseases · 1

Abstract 1524: M402, a novel heparan sulfate mimetic, inhibits pancreatic tumor growth and desmoplasia potentially via sonic hedgehog signaling in an orthotopic mouse model

2012 · Chia Lin Chu, Alison Long, et al. · Cancer Research · 1

Synergistic Activity of Adenosine A2A and Beta-2 Adrenergic Receptor Agonists in Myeloma Cells in the Context of Tumor-Stromal Interactions

2008 · Douglas W. McMillin, Richard Rickles, et al. · Blood · 1

Abstract 3113: M402, a novel heparan sulfate mimetic, modulates the desmoplastic response in an orthotopic pancreatic cancer model in mice

2011 · Chia Lin Chu, Alison Long, et al. · Cancer Research

Works count: 21

Citation count: 2,478

H-index: 10

I10-index: 10